Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae

Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Alt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2004-11, Vol.279 (47), p.48794-48800
Hauptverfasser: Lungu, Andreea O, Jin, Zheng-Gen, Yamawaki, Hideyuki, Tanimoto, Tatsuo, Wong, Chelsea, Berk, Bradford C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 48800
container_issue 47
container_start_page 48794
container_title The Journal of biological chemistry
container_volume 279
creator Lungu, Andreea O
Jin, Zheng-Gen
Yamawaki, Hideyuki
Tanimoto, Tatsuo
Wong, Chelsea
Berk, Bradford C
description Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 μ m CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress = 12 dynes/cm 2 ). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo , CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of β-cyclodextrin, a cholesterol-binding molecule, and β-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 μg/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.
doi_str_mv 10.1074/jbc.M313897200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67068303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17853480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-7df44e7bb65fc1bfc18d4a2a82f5c8379d120eb613f904075139b7e5f7638a973</originalsourceid><addsrcrecordid>eNqFkcFrFTEQxoMo9lm9epQcpLd9JptkkxwfS6uFVg8qeAtJdrabkrd5bvJa380_3ZT3oEcHhmHgN98M8yH0npI1JZJ_und-fcsoU1q2hLxAK0oUa5igv16iFSEtbXQr1Bl6k_M9qcE1fY3OqGCKibZbob_9wceUd2kJM97g63kKLpSMr2J6bLYwBFtgwBtfwoMtIc04jfhyHlKZIAYb8ddQluCb9CcMgL8f5jLZDNgd8CYWqJp3uJ9ShFybFHGf5gJzwXVXbx8gRQtv0avRxgzvTvUc_by6_NF_aW6-fb7uNzeN50KXRg4j5yCd68ToqaupBm5bq9pReMWkHmhLwHWUjZpwIgVl2kkQo-yYslqyc3Rx1N0t6fe-HmS2IXuI0c6Q9tl0knSKEfZfkEolGFekgusj6JeU8wKj2S1ha5eDocQ8mWOqOebZnDrw4aS8d_W1z_jJjQp8PAJTuJsewwLGheQn2JpWasOl4Upqzv4BzISX-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17853480</pqid></control><display><type>article</type><title>Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lungu, Andreea O ; Jin, Zheng-Gen ; Yamawaki, Hideyuki ; Tanimoto, Tatsuo ; Wong, Chelsea ; Berk, Bradford C</creator><creatorcontrib>Lungu, Andreea O ; Jin, Zheng-Gen ; Yamawaki, Hideyuki ; Tanimoto, Tatsuo ; Wong, Chelsea ; Berk, Bradford C</creatorcontrib><description>Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 μ m CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress = 12 dynes/cm 2 ). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo , CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of β-cyclodextrin, a cholesterol-binding molecule, and β-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 μg/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M313897200</identifier><identifier>PMID: 15383526</identifier><language>eng</language><publisher>United States: American Society for Biochemistry and Molecular Biology</publisher><subject>Adenoviridae - genetics ; Animals ; Aorta - metabolism ; beta-Cyclodextrins - pharmacology ; Blotting, Western ; Cattle ; Cell Membrane - metabolism ; Cells, Cultured ; Cholesterol - metabolism ; Cyclic AMP-Dependent Protein Kinases - chemistry ; Cyclosporine - pharmacology ; Detergents - pharmacology ; Endothelium, Vascular - enzymology ; Endothelium, Vascular - metabolism ; Enzyme Activation ; Immunoblotting ; Immunosuppressive Agents - pharmacology ; Kinetics ; Nitric Oxide - metabolism ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type III ; Phosphorylation ; Protein-Serine-Threonine Kinases - chemistry ; Proto-Oncogene Proteins - chemistry ; Proto-Oncogene Proteins c-akt ; Rabbits ; Serine - chemistry ; Stress, Mechanical ; Time Factors</subject><ispartof>The Journal of biological chemistry, 2004-11, Vol.279 (47), p.48794-48800</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-7df44e7bb65fc1bfc18d4a2a82f5c8379d120eb613f904075139b7e5f7638a973</citedby><cites>FETCH-LOGICAL-c459t-7df44e7bb65fc1bfc18d4a2a82f5c8379d120eb613f904075139b7e5f7638a973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15383526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lungu, Andreea O</creatorcontrib><creatorcontrib>Jin, Zheng-Gen</creatorcontrib><creatorcontrib>Yamawaki, Hideyuki</creatorcontrib><creatorcontrib>Tanimoto, Tatsuo</creatorcontrib><creatorcontrib>Wong, Chelsea</creatorcontrib><creatorcontrib>Berk, Bradford C</creatorcontrib><title>Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 μ m CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress = 12 dynes/cm 2 ). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo , CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of β-cyclodextrin, a cholesterol-binding molecule, and β-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 μg/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.</description><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>Aorta - metabolism</subject><subject>beta-Cyclodextrins - pharmacology</subject><subject>Blotting, Western</subject><subject>Cattle</subject><subject>Cell Membrane - metabolism</subject><subject>Cells, Cultured</subject><subject>Cholesterol - metabolism</subject><subject>Cyclic AMP-Dependent Protein Kinases - chemistry</subject><subject>Cyclosporine - pharmacology</subject><subject>Detergents - pharmacology</subject><subject>Endothelium, Vascular - enzymology</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Enzyme Activation</subject><subject>Immunoblotting</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Kinetics</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Phosphorylation</subject><subject>Protein-Serine-Threonine Kinases - chemistry</subject><subject>Proto-Oncogene Proteins - chemistry</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Rabbits</subject><subject>Serine - chemistry</subject><subject>Stress, Mechanical</subject><subject>Time Factors</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFrFTEQxoMo9lm9epQcpLd9JptkkxwfS6uFVg8qeAtJdrabkrd5bvJa380_3ZT3oEcHhmHgN98M8yH0npI1JZJ_und-fcsoU1q2hLxAK0oUa5igv16iFSEtbXQr1Bl6k_M9qcE1fY3OqGCKibZbob_9wceUd2kJM97g63kKLpSMr2J6bLYwBFtgwBtfwoMtIc04jfhyHlKZIAYb8ddQluCb9CcMgL8f5jLZDNgd8CYWqJp3uJ9ShFybFHGf5gJzwXVXbx8gRQtv0avRxgzvTvUc_by6_NF_aW6-fb7uNzeN50KXRg4j5yCd68ToqaupBm5bq9pReMWkHmhLwHWUjZpwIgVl2kkQo-yYslqyc3Rx1N0t6fe-HmS2IXuI0c6Q9tl0knSKEfZfkEolGFekgusj6JeU8wKj2S1ha5eDocQ8mWOqOebZnDrw4aS8d_W1z_jJjQp8PAJTuJsewwLGheQn2JpWasOl4Upqzv4BzISX-Q</recordid><startdate>20041119</startdate><enddate>20041119</enddate><creator>Lungu, Andreea O</creator><creator>Jin, Zheng-Gen</creator><creator>Yamawaki, Hideyuki</creator><creator>Tanimoto, Tatsuo</creator><creator>Wong, Chelsea</creator><creator>Berk, Bradford C</creator><general>American Society for Biochemistry and Molecular Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20041119</creationdate><title>Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae</title><author>Lungu, Andreea O ; Jin, Zheng-Gen ; Yamawaki, Hideyuki ; Tanimoto, Tatsuo ; Wong, Chelsea ; Berk, Bradford C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-7df44e7bb65fc1bfc18d4a2a82f5c8379d120eb613f904075139b7e5f7638a973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>Aorta - metabolism</topic><topic>beta-Cyclodextrins - pharmacology</topic><topic>Blotting, Western</topic><topic>Cattle</topic><topic>Cell Membrane - metabolism</topic><topic>Cells, Cultured</topic><topic>Cholesterol - metabolism</topic><topic>Cyclic AMP-Dependent Protein Kinases - chemistry</topic><topic>Cyclosporine - pharmacology</topic><topic>Detergents - pharmacology</topic><topic>Endothelium, Vascular - enzymology</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Enzyme Activation</topic><topic>Immunoblotting</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Kinetics</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Phosphorylation</topic><topic>Protein-Serine-Threonine Kinases - chemistry</topic><topic>Proto-Oncogene Proteins - chemistry</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Rabbits</topic><topic>Serine - chemistry</topic><topic>Stress, Mechanical</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lungu, Andreea O</creatorcontrib><creatorcontrib>Jin, Zheng-Gen</creatorcontrib><creatorcontrib>Yamawaki, Hideyuki</creatorcontrib><creatorcontrib>Tanimoto, Tatsuo</creatorcontrib><creatorcontrib>Wong, Chelsea</creatorcontrib><creatorcontrib>Berk, Bradford C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lungu, Andreea O</au><au>Jin, Zheng-Gen</au><au>Yamawaki, Hideyuki</au><au>Tanimoto, Tatsuo</au><au>Wong, Chelsea</au><au>Berk, Bradford C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2004-11-19</date><risdate>2004</risdate><volume>279</volume><issue>47</issue><spage>48794</spage><epage>48800</epage><pages>48794-48800</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 μ m CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress = 12 dynes/cm 2 ). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo , CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of β-cyclodextrin, a cholesterol-binding molecule, and β-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 μg/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.</abstract><cop>United States</cop><pub>American Society for Biochemistry and Molecular Biology</pub><pmid>15383526</pmid><doi>10.1074/jbc.M313897200</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2004-11, Vol.279 (47), p.48794-48800
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_67068303
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adenoviridae - genetics
Animals
Aorta - metabolism
beta-Cyclodextrins - pharmacology
Blotting, Western
Cattle
Cell Membrane - metabolism
Cells, Cultured
Cholesterol - metabolism
Cyclic AMP-Dependent Protein Kinases - chemistry
Cyclosporine - pharmacology
Detergents - pharmacology
Endothelium, Vascular - enzymology
Endothelium, Vascular - metabolism
Enzyme Activation
Immunoblotting
Immunosuppressive Agents - pharmacology
Kinetics
Nitric Oxide - metabolism
Nitric Oxide Synthase - metabolism
Nitric Oxide Synthase Type III
Phosphorylation
Protein-Serine-Threonine Kinases - chemistry
Proto-Oncogene Proteins - chemistry
Proto-Oncogene Proteins c-akt
Rabbits
Serine - chemistry
Stress, Mechanical
Time Factors
title Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A33%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclosporin%20A%20Inhibits%20Flow-mediated%20Activation%20of%20Endothelial%20Nitric-oxide%20Synthase%20by%20Altering%20Cholesterol%20Content%20in%20Caveolae&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Lungu,%20Andreea%20O&rft.date=2004-11-19&rft.volume=279&rft.issue=47&rft.spage=48794&rft.epage=48800&rft.pages=48794-48800&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M313897200&rft_dat=%3Cproquest_cross%3E17853480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17853480&rft_id=info:pmid/15383526&rfr_iscdi=true